Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac inj...

por Sheng, Calvin C, Sahoo, Debasis, Dugar, Siddharth, Prada, Robier Aguillon, Wang, Tom Kai Ming, Abou Hassan, Ossama K, Brennan, Danielle, Culver, Daniel A, Rajendram, Prabalini, Duggal, Abhijit, Lincoff, A Michael, Nissen, Steven E, Menon, Venu, Cremer, Paul C
Publicado 2020

Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation

por Cremer, Paul C, Sheng, Calvin C, Sahoo, Debasis, Dugar, Siddharth, Prada, Robier Aguillon, Wang, Tom Kai Ming, Hassan, Ossama K Abou, Hernandez-Montfort, Jamie, Wolinsky, David A, Culver, Daniel A, Rajendram, Prabalini, Duggal, Abhijit, Brennan, Danielle M, Wolski, Katherine E, Lincoff, A Michael, Nissen, Steven E, Menon, Venu
Publicado 2021